ArticleOncoTargets and therapy2021

FAST1 Predicts Poor Survival of Renal Carcinoma and Promotes Its Progression Through the TGF-β/Smad Pathway.

Tao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.